Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer
Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas
Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer
ASCO 2026: Highlights and analysis
Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours
Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type metastatic colorectal cancer
Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety
Structured exercise programme improves survival and reduces healthcare costs in colon cancer
Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps
Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma
Bezuclastinib sunitinib combo shows promise in second-line GIST treatment